Data / Form D filings / TORIGEN PHARMACEUTICALS, INC.
TORIGEN PHARMACEUTICALS, INC.: Form D filings
TORIGEN PHARMACEUTICALS, INC., a pharmaceuticals company in Farmington, CT, filed 5 Form D notices with the SEC between 2019 and 2022. The latest, on May 24, 2022, reports $4.6 million sold of a $10 million offering to 30 investors.
Find out what TORIGEN PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 FARMINGTON AVE., R1855 CB129, Farmington, CT, 06032
- Phone
- (860) 519-9956
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1764961
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 24, 2022 | New notice | $10,000,000 | $4,601,438 | $5,398,562 | 30 | May 9, 2022 | sec.gov |
| Dec 6, 2021 | New notice | $1,500,000 | $1,223,912 | $276,088 | 16 | Nov 22, 2021 | sec.gov |
| Mar 5, 2021 | Amendment | $3,500,000 | $3,272,000 | $228,000 | 38 | Jun 2, 2020 | sec.gov |
| Jun 16, 2020 | New notice | $1,500,000 | $613,000 | $887,000 | 10 | Jun 2, 2020 | sec.gov |
| Jan 16, 2019 | New notice | $2,000,000 | $1,760,000 | $240,000 | 9 | Jan 4, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Blake Hawley | Director | |
| Kevin Crowley | Director | |
| John Kallassy | Executive Officer | |
| Musan Duric | Director | |
| Ashley Kalinauskas | Executive Officer, Director | |
| Elizabeth Galbut | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of May 23, 2022 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TORIGEN PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.